Infective endocarditis at a hospital in Saudi Arabia: Epidemiology, bacterial pathogens and outcome

Annals of Saudi Medicine

Volumn 29, Issue 6, 2009, Pages 433-436

  Al Tawfiq, Jaffar A ^a   Sufi, Ismail ^a  

^a DHAHRAN HEALTH CENTER   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALPHA HEMOLYTIC STREPTOCOCCUS; AORTA VALVE; ARTICLE; BACTERIAL ENDOCARDITIS; BACTERIAL VIRULENCE; DISEASE PREDISPOSITION; ENTEROCOCCUS FAECALIS; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE; MORTALITY; PRIORITY JOURNAL; PROSTHETIC VALVE ENDOCARDITIS; RETROSPECTIVE STUDY; SAUDI ARABIA; STAPHYLOCOCCUS AUREUS; STROKE;

ADULT; AGED; DATABASES, FACTUAL; ENDOCARDITIS, BACTERIAL; FEMALE; HEART VALVE DISEASES; HEART VALVE PROSTHESIS; HOSPITAL MORTALITY; HOSPITALS; HUMANS; MALE; MIDDLE AGED; PREVALENCE; PROSTHESIS-RELATED INFECTIONS; RETROSPECTIVE STUDIES; SAUDI ARABIA;

EID: 71049151219     PISSN: 02564947     EISSN: 13199226     Source Type: Journal    
DOI: 10.4103/0256-4947.57164     Document Type: Article

References (29)

1. Cabell CH, Jollis JG, Peterson GE, Corey GR, Anderson DJ, Sexton DJ, et al. Changing patient characteristics and the effect on mortality in endocarditis. Arch Intern Med 2002;162:90-94 (Pubitemid 34073406)
2. Hoen B, Alla F, Selton-Suty C, Béguinot I, Bouvet A, Briançon S, et al. Changing profile of infective endocarditis: Results of a 1-year survey in France. JAMA 2002;288:75-81. (Pubitemid 34705521)
3. Alshammary A, Hervas-Malo M, Robinson JL. Pediatric infective endocarditis: Has S aureus overtaken viridans group streptococci as the predominant etiological agent? Can J Infect Dis Med Microbiol 2008;19:63-68
4. Nashmi A, Memish ZA. Infective endocarditis at a tertiary care centre in Saudi Arabia: Review of 47 cases over 10 years. East Mediterr Health J 2007;13:64-71. (Pubitemid 47243842)
5. Wilson WR, Karchmer AW, Dajani AS, Taubert KA, Bayer A, Kaye D, et al. Antibiotic treatment of adults with infective endocarditis due to streptococci, enterococci, staphylococci, and HACEK microorganisms: American Heart Association. JAMA 1995;274:1706-1713
6. Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG Jr, Ryan T, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 2000;30:633-638 (Pubitemid 30736964)
7. Garg N, Kandpal B, Garg N, Tewari S, Kapoor A, Goel P, et al. Characteristics of infective endocarditis in a developing country-clinical profile and outcome in 192 Indian patients, 1992-2001. Int J Cardiol 2005;158:253-260
8. Letaief A, Boughzala E, Kaabia N, Ernez S, Abid F, Ben Chaabane T, et al. Epidemiology of infective endocarditis in Tunisia: A 10-year multicenter retrospective study. Int J Infect Dis 2007;11:430-433 (Pubitemid 47243809)
9. Trabelsi I, Rekik S, Znazen A, Maaloul I, Abid D, Maalej A, et al. Native valve infective endocarditis in a tertiary care center in a developing country (Tunisia). Am J Cardiol 2008;102:1247-1251
10. Kiwan YA, Hayat N, Vijayaraghavan DG, Das Chugh T, Khan N, Mualla F, et al. Infective endocarditis: A prospective study of 60 consecutive cases. Mater Med Pol 1990;22:173-175
11. Hill EE, Herijgers P, Claus P, Vanderschueren S, Herregods MC, Peetermans WE. Infective endocarditis: Changing epidemiology and predictors of 6-month mortality: A prospective cohort study. Eur Heart J 2007;28:196-203. (Pubitemid 46269878)
12. Durante-Mangoni E, Bradley S, Selton-Suty C, Tripodi MF, Barsic B, Bouza E, et al. Current features of infective endocarditis in elderly patients: Results of the International Collaboration on Endocarditis Prospective Cohort Study. Arch Intern Med 2008;168:2095-2103
13. Murdoch DR, Corey GR, Hoen B, Miró JM, Fowler VG Jr, Bayer AS, et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: The International Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med 2009;169:463-473
14. Netzer RO, Altwegg SC, Zollinger E, Täuber M, Carrel T, Seiler C. Infective endocarditis: Determinants of long term outcome. Heart 2002;88:61-66 (Pubitemid 34665005)
15. Shively BK, Gurule FT, Roldan CA, Leggett JH, Schiller NB. Diagnostic value of transesophageal compared with transthoracic echocardiography in infective endocarditis. J Am Coll Cardiol 1991;18:391-397
16. Erbel R, Rohmann S, Drexler M, Mohr-Kahaly S, Gerharz CD, Iversen S, et al. Improved diagnostic value of echocardiography in patients with infective endocarditis by transoesophageal approach: A prospective study. Eur Heart J 1988;9:43-53. (Pubitemid 18111270)
17. Miro JM, Anguera I, Cabell CH, Chen AY, Stafford JA, Corey GR, et al. S aureus native valve infective endocarditis: Report of 566 episodes from the International Collaboration on Endocarditis Merged Database. Clin Infect Dis 2005;41:507-514
18. Sanabria TJ, Alpert JS, Goldberg R, Pape LA, Cheeseman SH. Increasing frequency of staphylococcal infective endocarditis: Experience at a university hospital, 1981 through 1988. Arch Intern Med 1990;150:1305-1309
19. Kanafani ZA, Mahfouz TH, Kanj SS. Infective endocarditis at a tertiary care centre in Lebanon: predominance of streptococcal infection. J Infect 2002;45:152-159
20. Al-Tawfiq JA. Incidence and epidemiology of methicillin-resistant S aureus infection in a Saudi Arabian Hospital, 1999-2003. Infect Control Hosp Epidemiol 2006;27:1137-1139
21. Al-Tawfiq JA, Kiwan G, Murrar H. Granulicatella elegans native valve infective endocarditis: Case report and review. Diagn Microbiol Infect Dis 2007;57:439-441 (Pubitemid 46509722)
22. American College of Cardiology; American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease); Society of Cardiovascular Anesthesiologists, Bonow RO, Carabello BA, Chatterjee K, et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing committee to revise the 1998 guidelines for the management of patients with valvular heart disease) guidelines for the management of patients with valvular heart disease) developed in collaboration with the Society of Cardiovascular Anesthesiologists endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. J Am Coll Cardiol 2006;48:e1-148.
23. Vikram HR, Buenconsejo J, Hasbun R, Quagliarello VJ. Impact of valve surgery on 6-month mortality in adults with complicated, left-sided native valve endocarditis: A propensity analysis. JAMA 2003;290:3207-3214 (Pubitemid 38020682)
24. Fowler VG Jr, Olsen MK, Corey GR, Woods CW, Cabell CH, Reller LB, et al. Clinical identifiers of complicated S aureus bacteremia. Arch Intern Med 2003;163:2066-2072
25. Bishara J, Leibovici L, Gartman-Israel D, Sagie A, Kazakov A, Miroshnik E, et al. Long-term outcome of infective endocarditis: The impact of early surgical intervention. Clin Infect Dis 2001;33:1636-1643 (Pubitemid 33044526)
26. Watanakunakorn C, Tan JS, Phair J. Some salient features of S aureus endocarditis. Am J Med 1973;54:473-481
27. Bayer AS. Staphylococcal bacteremia and endocarditis: State of the art. Arch Intern Med 1982;142:1169-1177
28. Thompson RL. Staphylococcal infective endocarditis. Mayo Clin Proc 1982;57:106-114
29. Nadji G, Rémadi JP, Coviaux F, Mirode AA, Brahim A, Enriquez-Sarano M, et al. Comparison of clinical and morphological characteristics of S aureus endocarditis with endocarditis caused by other pathogens. Heart 91:932-937